BLSM ▲ +0.1% - BlossomHill Therapeutics, Inc.
$BLSM - BlossomHill Therapeutics Announces Upcoming Presentation for BH-30236, an Oral Macrocyclic CLK Inhibitor, at the 68th American Society of Hematology (ASH) Annual Meeting
04-NOV-2026 07:00 AM ET
Share this post
More filings for $BLSM
BLSM ▲ +0.4% - BlossomHill Therapeutics, Inc.Nov 3, 2026BLSM ▲ +0.6% - BlossomHill Therapeutics, Inc.Oct 22, 2026BLSM ▲ +6.9% - BlossomHill Therapeutics, Inc.Sep 15, 2026BLSM ▲ +0.5% - BlossomHill Therapeutics, Inc.Sep 3, 2026BLSM ▼ -2.7% - BlossomHill Therapeutics, Inc.Sep 1, 2026
View full $BLSM filing history →💬 Comments
Loading comments…
Leave a comment